Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Executives On The Move: New Chief Financial Officer Joins Genfit, BioVie Gets New CEO

Executive Summary

Seneca shakes up leadership team with new CEO and chief financial officer, along with a board reshuffle.

You may also be interested in...



Executives On The Move: Changes At Medivir, And More

Magnus Christensen takes over as Medivir's interim CEO, while Yilmaz Mahshid joins the board. Meanwhile, bluebird bio appoints a new chief commercial officer for severe genetic disease and ARCA biopharma appoints a new CFO and VP of clinical development.

Coronavirus Update: New Funding For Valneva, Scotland Looks At Long COVID

France's Valneva raises new funds to progress its inactivated vaccine, while Scotland launches a new study into 'long COVID', Takeda reports positive interim results from a Japanese trial with Moderna's mRNA vaccine, a setback for GC's plasma therapy, and Celltrion begins exporting a therapeutic antibody. 

Executives On The Move: New CEOs At Advicenne, Almirall And CohBar

Executive reshuffle at Karyopharm Therapeutics, plus new chief financial officers at Redx Pharma and Vaccibody.

Topics

UsernamePublicRestriction

Register

SC144269

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel